Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | NA |
| Strategy: | DNA vaccines |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | In Progress |
| Study Start Date: | 2008-03-10 |
| Study Made Public: | NA |
Title
ADVAX
Description
CAVD 244 (ADVAX) is a Phase I clinical trial to evaluate the effect of two vaccinations with ADVAX (Clade C/B muligenic DNA-based vaccine) administered either via in vivo electroporation or standard intramuscular injection in 40 healthy HIV-negative volunteers.
Sign in to see full information about this study and to download study data.
Products
Saline (non-specific) ADVAXIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.